Literature DB >> 14742884

Diagnosis of osteoporosis in men, premenopausal women, and children.

.   

Abstract

The World Health Organization (WHO) classification of bone mineral density is based on population studies in postmenopausal women. However, the increased use of bone densitometry has raised questions regarding the applicability of this classification to men, premenopausal women, and children. These questions were addressed at the International Society for Clinical Densitometry 2003 Position Development Conference. T-scores can be used and a diagnosis of osteoporosis made for T-scores of -2.5 or less (male reference database) in men age 65 yr and older and in men from 50 to 64 yr of age if other risk factors for fracture are present. The WHO classification should not be applied to premenopausal women. Men and premenopausal women with secondary causes of low bone density or bone loss may be clinically diagnosed with osteoporosis, taking bone density into consideration. In children and adolescents (males and females less than 20 yr of age), there are no densitometric criteria for diagnosing osteoporosis. If Z-scores are -2.0 or less (using pediatric databases of age-matched controls), then a characterization such as "low bone density for chronologic age" is appropriate. In men under 50 yr of age, premenopausal women, and children, Z-scores, not T-scores, should be used when reporting bone density results.

Entities:  

Mesh:

Year:  2004        PMID: 14742884     DOI: 10.1385/jcd:7:1:17

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  59 in total

Review 1.  The association between metabolic syndrome and bone mineral density: a meta-analysis.

Authors:  Peng Xue; Ping Gao; Yukun Li
Journal:  Endocrine       Date:  2012-05-01       Impact factor: 3.633

2.  Normative bone mineral density z-scores for Canadians aged 16 to 24 years: the Canadian Multicenter Osteoporosis Study.

Authors:  Wei Zhou; Lisa Langsetmo; Claudie Berger; Jonathan D Adachi; Alexandra Papaioannou; George Ioannidis; Colin Webber; Stephanie A Atkinson; Wojciech P Olszynski; Jacques P Brown; David A Hanley; Robert Josse; Nancy Kreiger; Jerilynn Prior; Stephanie Kaiser; Susan Kirkland; David Goltzman; Kenneth Shawn Davison
Journal:  J Clin Densitom       Date:  2010-05-31       Impact factor: 2.617

Review 3.  Male osteoporosis: new trends in diagnosis and therapy.

Authors:  Hosam K Kamel
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Young patients with hip fracture: a population-based study of bone mass and risk factors for osteoporosis.

Authors:  C M Lofthus; E K Osnes; H E Meyer; I S Kristiansen; L Nordsletten; J A Falch
Journal:  Osteoporos Int       Date:  2006-08-29       Impact factor: 4.507

Review 5.  Genetic regulation of bone mass: from bone density to bone strength.

Authors:  Craig B Langman
Journal:  Pediatr Nephrol       Date:  2005-01-05       Impact factor: 3.714

6.  Bone mineral density in Norwegian premenopausal women.

Authors:  Elin Kolle; Monica Klungland Torstveit; Jorunn Sundgot-Borgen
Journal:  Osteoporos Int       Date:  2004-10-21       Impact factor: 4.507

Review 7.  Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review.

Authors:  S L Liu; C M Lebrun
Journal:  Br J Sports Med       Date:  2006-01       Impact factor: 13.800

Review 8.  Treatment of low bone mass in premenopausal women: when may it be appropriate?

Authors:  Edward S Leib
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

9.  Appropriateness of referrals to a tertiary referral centre for bone mineral density testing.

Authors:  A Mohammad; M U Aamir; S Mooney; R J Coughlan; J J Carey
Journal:  Ir J Med Sci       Date:  2013-11-30       Impact factor: 1.568

Review 10.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.